Literature DB >> 22743036

Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

Morgan A Reuter1, Carolina Pombo, Michael R Betts.   

Abstract

Numerous studies have characterized the cytokine modulation observed in human immunodeficiency virus (HIV) infected individuals, from initial infection through chronic disease. Progressive and non-progressive HIV infection models show the cytokine milieu differs in terms of production and responsiveness in these two groups, suggesting an understanding of the role cytokines play during infection is necessary for directing the immune response toward viral control. This review will cover cytokine induction and dysfunction during HIV pathogenesis, with a focus on the interplay between cytokines and transcription factors, T cell activation, and exhaustion. We highlight cytokines that have either vaccine adjuvant or therapeutic potential and discuss the need to identify key factors required for prevention of progression, clearance of infection, or protection from acquisition.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743036      PMCID: PMC3582023          DOI: 10.1016/j.cytogfr.2012.05.005

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  170 in total

1.  Germinal centre CD4+ T cells are an important site of HIV replication in vivo.

Authors:  F T Hufert; J van Lunzen; G Janossy; S Bertram; J Schmitz; O Haller; P Racz; D von Laer
Journal:  AIDS       Date:  1997-06       Impact factor: 4.177

2.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

3.  Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection.

Authors:  J Vingerhoets; E Bisalinkumi; G Penne; R Colebunders; E Bosmans; L Kestens; G Vanham
Journal:  Immunol Lett       Date:  1998-03       Impact factor: 3.685

4.  Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.

Authors:  R T Davey; D G Chaitt; S C Piscitelli; M Wells; J A Kovacs; R E Walker; J Falloon; M A Polis; J A Metcalf; H Masur; G Fyfe; H C Lane
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

5.  IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.

Authors:  K Q Xin; K Hamajima; S Sasaki; T Tsuji; S Watabe; E Okada; K Okuda
Journal:  Vaccine       Date:  1999-02-26       Impact factor: 3.641

6.  Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes.

Authors:  S Dhawan; A Heredia; L M Wahl; J S Epstein; M S Meltzer; I K Hewlett
Journal:  Pathobiology       Date:  1995       Impact factor: 4.342

7.  Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.

Authors:  X Han; K Becker; H J Degen; H Jablonowski; G Strohmeyer
Journal:  Eur J Clin Invest       Date:  1996-04       Impact factor: 4.686

8.  IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.

Authors:  X Xu; X Y Fu; J Plate; A S Chong
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

9.  Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells.

Authors:  J K Lazdins; M Grell; M R Walker; K Woods-Cook; P Scheurich; K Pfizenmaier
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  26 in total

1.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.

Authors:  Salum J Lidenge; For Yue Tso; Owen Ngalamika; John R Ngowi; Yasaman Mortazavi; Eun Hee Kwon; Danielle M Shea; Veenu Minhas; Julius Mwaiselage; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

Authors:  Bin Su; Maryse Peressin; Camille Ducloy; Julien Penichon; Luzia M Mayr; Géraldine Laumond; Sylvie Schmidt; Thomas Decoville; Christiane Moog
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-10       Impact factor: 2.205

4.  HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127.

Authors:  Rebecca B Hasley; Changwan Hong; Wenqing Li; Travis Friesen; Yoriko Nakamura; Grace Y Kim; Jung-Hyun Park; Julie A Hixon; Scott Durum; Zonghui Hu; Michael C Sneller; Raphael Oguariri; Tomozumi Imamichi; H Clifford Lane; Marta Catalfamo
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

5.  Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Giuseppe Liotta; Mauro Andreotti; Sandro Mancinelli; Robert Mphwere; Enok Bokola; Roberta Amici; Maria Cristina Marazzi; Leonardo Palombi; Francesca Lucaroni; Marina Giuliano
Journal:  Med Microbiol Immunol       Date:  2018-02-27       Impact factor: 3.402

Review 6.  Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.

Authors:  Shahzada Khan; Sushama Telwatte; Martin Trapecar; Steven Yukl; Shomyseh Sanjabi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

7.  The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.

Authors:  Jeffrey M Jacobson; Lu Zheng; Cara C Wilson; Pablo Tebas; Roy M Matining; Michael A Egan; John Eldridge; Alan L Landay; David B Clifford; Anne F Luetkemeyer; Jennifer Tiu; Ana L Martinez; Jennifer Janik; Teresa A Spitz; John Hural; Juliana McElrath; Nicole Frahm
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

8.  P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.

Authors:  Alexandra Y Soare; Natasha D Durham; Ramya Gopal; Benjamin Tweel; Kevin W Hoffman; Julia A Brown; Megan O'Brien; Nina Bhardwaj; Jean K Lim; Benjamin K Chen; Talia H Swartz
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

9.  Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Authors:  Christophe Vanpouille; Andrea Introini; Sheldon R Morris; Leonid Margolis; Eric S Daar; Michael P Dube; Susan J Little; David M Smith; Andrea Lisco; Sara Gianella
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

10.  Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal Immunopathology.

Authors:  Katharine J Bar; Ernesto Coronado; Tiffany Hensley-McBain; Megan A O'Connor; Jessica M Osborn; Charlene Miller; Toni M Gott; Solomon Wangari; Naoto Iwayama; Chul Y Ahrens; Jeremy Smedley; Cassie Moats; Rebecca M Lynch; Elias K Haddad; Nancy L Haigwood; Deborah H Fuller; George M Shaw; Nichole R Klatt; Jennifer A Manuzak
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.